acetylcysteine has been researched along with Heart Diseases in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (11.11) | 18.7374 |
| 1990's | 3 (11.11) | 18.2507 |
| 2000's | 8 (29.63) | 29.6817 |
| 2010's | 11 (40.74) | 24.3611 |
| 2020's | 2 (7.41) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, AWH; Chan, DPC; Chan, JYW; Ji, X; Lee, SMY; Lee, SS; Leung, RKK; Li, J; Ng, PCI; Ren, Z; Wang, R; Xu, Y; Yew, WW; Zheng, J | 1 |
| He, YL; Li, XM; Nie, F; Xiong, Y; Zhou, XK | 1 |
| Gharibeh, L; Harper, ME; Ichim, B; Kanaan, GN; Maharsy, W; Marshall, P; Menzies, K; Nemer, M; Patten, DA; Reunov, A; Veinot, J; Xuan, JY | 1 |
| Braz, LG; El Dib, R; Escudero, J; Hayes, J; Johnston, BC; Pereira, JEG | 1 |
| Bai, D; Gao, Y; Ge, L; Lu, X; Wang, H; Yang, G | 1 |
| El Kiki, SM; Hasan, HF; Mansour, HH | 1 |
| Chen, L; He, J; Li, J; Lin, XL; Liu, J; Liu, MH; Tan, TP; Tian, W; Wu, SJ; Yu, S; Yuan, C; Zhang, Y | 1 |
| Chandra, J; Egas-Bejar, DE; Fulbright, JM; Huh, WW | 1 |
| Ilic, M; Jakovljevic, V; Joksimovic, J; Mitrovic, S; Orescanin-Dusic, Z; Rosic, G; Selakovic, D; Srejovic, I; Tatalović, N; Zivkovic, V | 1 |
| Angioli, P; Bolognese, L; Carrera, A; Ducci, K; Falsini, G; Grotti, S; Liistro, F; Limbruno, U; Picchi, A; Pierli, C | 1 |
| Amauchi, JF; Cataneo, AC; Ebaid, GX; Fernandes, AA; Novelli, EL; Rocha, KK; Seiva, FR; Souza, G | 1 |
| Arya, S; Contractor, H; Gauge, V; Nabi, S; Naqvi, N; Titu, H | 1 |
| Islam, KN; Koch, WJ | 1 |
| Benjamin, IJ; Brewer, AC; Murray, TV; Mustafi, SB; Rajasekaran, NS | 1 |
| Ghelfi, E; González-Flecha, B; Lawrence, J; Rhoden, CR; Wellenius, GA | 1 |
| Krizova, B; Sochman, J | 1 |
| Guo, Z; McNeill, JH; Nagareddy, PR; Xia, Z; Yeung, E; Yuen, V | 1 |
| Bortone, F; Ceriani, R; Fiorentini, C; Juliano, G; Marenzi, G; Salvi, L; Sisillo, E; Veglia, F | 1 |
| Bouman, CC; Schultz, MJ | 1 |
| Litovitz, TL | 1 |
| Giese, C; Hannemann, L; Meier-Hellmann, A; Reinhart, K; Schaffartzik, W; Specht, M; Spies, C | 1 |
| Buikema, H; Crijns, HJ; de Zeeuw, D; Monnink, SH; Tio, RA; van Gilst, WH | 1 |
| Gustafson, DL; Pritsos, CA; Sokoloff, M | 1 |
| Monti, E; Paracchini, L; Perletti, G; Piccinini, F | 1 |
| Ferrans, VJ; Herman, EH | 1 |
| Carnimeo, N; Iaia, E | 1 |
3 review(s) available for acetylcysteine and Heart Diseases
| Article | Year |
|---|---|
N-acetylcysteine use among patients undergoing cardiac surgery: A systematic review and meta-analysis of randomized trials.
Topics: Acetylcysteine; Biomarkers; Cardiac Surgical Procedures; Heart Diseases; Humans; Mortality; Odds Ratio; Prognosis; Publication Bias; Randomized Controlled Trials as Topic; Treatment Outcome; Workflow | 2019 |
Reductive stress linked to small HSPs, G6PD, and Nrf2 pathways in heart disease.
Topics: Acetylcysteine; alpha-Crystallin B Chain; Animals; Antioxidants; Catalase; Disease Models, Animal; Early Diagnosis; Glucosephosphate Dehydrogenase; Glutathione; Heart Diseases; Heat-Shock Proteins; Humans; Mice; Models, Cardiovascular; Molecular Chaperones; Neoplasm Proteins; NF-E2-Related Factor 2; Peroxidases; Precision Medicine; Reactive Nitrogen Species; Reactive Oxygen Species; Recombinant Fusion Proteins; Superoxide Dismutase; Thioredoxins | 2013 |
The anecdotal antidotes.
Topics: Acetylcysteine; Adult; Aged; Animals; Antidotes; Child; Cimetidine; Female; Ferrocyanides; Folic Acid; Heart Diseases; Humans; Magnesium; Male; Middle Aged; Naloxone; Niacinamide; Physostigmine; Poisoning; Pyridoxine; Thioctic Acid | 1984 |
4 trial(s) available for acetylcysteine and Heart Diseases
| Article | Year |
|---|---|
The contrast media and nephrotoxicity following coronary revascularization by primary angioplasty for acute myocardial infarction study: design and rationale of the CONTRAST-AMI study.
Topics: Acetylcysteine; Acute Kidney Injury; Angioplasty, Balloon, Coronary; Biomarkers; Contrast Media; Coronary Angiography; Creatinine; Heart Diseases; Humans; Iohexol; Italy; Myocardial Infarction; Prospective Studies; Research Design; Single-Blind Method; Syndrome; Time Factors; Treatment Outcome; Triiodobenzoic Acids | 2010 |
Prevention of contrast agent-induced renal impairment in patients with chronic renal insufficiency and heart disease by high-dose intravenous N-acetylcysteine: a pilot-ministudy.
Topics: Acetylcysteine; Acute Kidney Injury; Contrast Media; Coronary Angiography; Creatinine; Heart Diseases; Humans; Infusions, Intravenous; Pilot Projects; Poland; Premedication; Renal Insufficiency, Chronic; Safety; Treatment Outcome | 2006 |
N-acetylcysteine for prevention of acute renal failure in patients with chronic renal insufficiency undergoing cardiac surgery: a prospective, randomized, clinical trial.
Topics: Acetylcysteine; Acute Kidney Injury; Aged; Creatinine; Female; Free Radical Scavengers; Heart Diseases; Humans; Length of Stay; Male; Prospective Studies; Renal Insufficiency, Chronic; Renal Replacement Therapy; Treatment Outcome | 2008 |
[The effect of prophylactically administered n-acetylcysteine on clinical indicators for tissue oxygenation during hyperoxic ventilation in cardiac risk patients].
Topics: Acetylcysteine; Cardiac Output; Female; Free Radical Scavengers; Heart Diseases; Hemodynamics; Humans; Hyperoxia; Male; Middle Aged; Oxygen Consumption; Prospective Studies; Respiration, Artificial; Risk Factors | 1996 |
20 other study(ies) available for acetylcysteine and Heart Diseases
| Article | Year |
|---|---|
Role of oxidative stress in clofazimine-induced cardiac dysfunction in a zebrafish model.
Topics: Acetylcysteine; Animals; Antitubercular Agents; Clofazimine; Disease Models, Animal; Gene Expression Profiling; Heart Diseases; Oxidative Stress; Zebrafish | 2020 |
Endogenous asymmetric dimethylarginine accumulation precipitates the cardiac and mitochondrial dysfunctions in type 1 diabetic rats.
Topics: Acetylcysteine; Animals; Arginine; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Free Radical Scavengers; Glycosylation; Heart Diseases; Insulin Resistance; Male; Mitochondria; Myocardial Contraction; Myocytes, Cardiac; Nitric Oxide; Papillary Muscles; Rats, Sprague-Dawley; Signal Transduction; Streptozocin | 2021 |
Glutaredoxin-2 controls cardiac mitochondrial dynamics and energetics in mice, and protects against human cardiac pathologies.
Topics: Acetylcysteine; Animals; Cardiomegaly; Cells, Cultured; Energy Metabolism; Glutaredoxins; Heart Diseases; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitochondria; Mitochondrial Dynamics; Oxidation-Reduction; Oxidative Stress; Protective Factors | 2018 |
Cytoplasmic translocation of HuR contributes to angiotensin II induced cardiac fibrosis.
Topics: Acetylcysteine; Angiotensin II; Animals; Collagen; Cytoplasm; Dose-Response Relationship, Drug; ELAV Proteins; Heart Diseases; Male; Mice; Mice, Inbred C57BL; Protein Transport; Reactive Oxygen Species; Transforming Growth Factor beta | 2015 |
Protective effect of N-acetylcysteine on cyclophosphamide-induced cardiotoxicity in rats.
Topics: Acetylcysteine; Animals; Cardiotoxicity; Cyclophosphamide; Disease Models, Animal; Gene Expression Regulation, Enzymologic; Heart Diseases; Male; Malondialdehyde; Nitric Oxide; Oxidative Stress; Rats; Rats, Wistar | 2015 |
Hydrogen sulfide attenuates doxorubicin-induced cardiotoxicity by inhibiting reactive oxygen species-activated extracellular signal-regulated kinase 1/2 in H9c2 cardiac myocytes.
Topics: Acetylcysteine; Animals; Antibiotics, Antineoplastic; Cardiotonic Agents; Cell Line; Cystathionine gamma-Lyase; Doxorubicin; Drug Evaluation, Preclinical; Enzyme Activation; Free Radical Scavengers; Heart Diseases; Hydrogen Sulfide; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Myocytes, Cardiac; Oxidative Stress; Phosphorylation; Protein Processing, Post-Translational; Rats; Reactive Oxygen Species | 2015 |
Analysis of redox and apoptotic effects of anthracyclines to delineate a cardioprotective strategy.
Topics: Acetylcysteine; Acute Disease; Adolescent; Animals; Anthracyclines; Antioxidants; Apoptosis; Cardiotonic Agents; Cell Line; Cell Line, Tumor; Child, Preschool; Female; Heart Diseases; Humans; Jurkat Cells; Leukemia; Leukocytes, Mononuclear; Male; Mice, Inbred BALB C; Mice, SCID; Myocytes, Cardiac; Oxidation-Reduction; Oxidative Stress; Rats; Reactive Oxygen Species | 2015 |
The effects of N-acetylcysteine on cisplatin-induced changes of cardiodynamic parameters within coronary autoregulation range in isolated rat hearts.
Topics: Acetylcysteine; Animals; Antioxidants; Biomarkers; Cardiotonic Agents; Cisplatin; Coronary Circulation; Coronary Vessels; Cytoprotection; Disease Models, Animal; Heart Diseases; Heart Rate; Homeostasis; Isolated Heart Preparation; Male; Myocytes, Cardiac; Oxidative Stress; Rats, Wistar; Ventricular Function, Left; Ventricular Pressure | 2016 |
Alcoholism and alcohol abstinence: N-acetylcysteine to improve energy expenditure, myocardial oxidative stress, and energy metabolism in alcoholic heart disease.
Topics: Acetylcysteine; Alcoholism; Animals; Energy Metabolism; Heart Diseases; Male; Myocardium; Oxidative Stress; Oxygen Consumption; Rats; Rats, Wistar; Temperance | 2009 |
ST segment elevation secondary to paracetamol overdose.
Topics: Acetaminophen; Acetylcysteine; Aged; Analgesics, Non-Narcotic; Antidotes; Coronary Angiography; Drug Overdose; Electrocardiography; Female; Heart Diseases; Humans | 2011 |
Involvement of nuclear factor κB (NF-κB) signaling pathway in regulation of cardiac G protein-coupled receptor kinase 5 (GRK5) expression.
Topics: Acetylcysteine; Animals; G-Protein-Coupled Receptor Kinase 5; Gene Expression Regulation, Enzymologic; Heart Diseases; Myocytes, Cardiac; NF-kappa B p50 Subunit; Primary Cell Culture; Promoter Regions, Genetic; Rats; Reactive Oxygen Species; RNA, Small Interfering; Signal Transduction; Tetradecanoylphorbol Acetate; Thiophenes; Transcription Factor RelA | 2012 |
PM-induced cardiac oxidative stress and dysfunction are mediated by autonomic stimulation.
Topics: Acetylcholine; Acetylcysteine; Air Pollutants; Animals; Autonomic Agents; Autonomic Nervous System; Glycopyrrolate; Heart Diseases; Heart Rate; Inhalation Exposure; Isoproterenol; Male; Muscarine; Oxidative Stress; Particle Size; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species | 2005 |
Antioxidant N-acetylcysteine restores myocardial Mn-SOD activity and attenuates myocardial dysfunction in diabetic rats.
Topics: Acetylcysteine; Animals; Antioxidants; Diabetes Mellitus, Experimental; Free Radical Scavengers; Heart Diseases; Immunoenzyme Techniques; Male; Myocardium; Oxidative Stress; Rats; Rats, Wistar; Superoxide Dismutase | 2006 |
N-acetylcysteine: multiple organ saver during cardiac surgery?
Topics: Acetylcysteine; Acute Kidney Injury; Free Radical Scavengers; Heart Diseases; Humans; Research Design; Treatment Outcome | 2008 |
Comparison of zofenopril and lisinopril to study the role of the sulfhydryl-group in improvement of endothelial dysfunction with ACE-inhibitors in experimental heart failure.
Topics: Acetylcholine; Acetylcysteine; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Thoracic; Blood Pressure; Body Weight; Calcimycin; Captopril; Endothelium, Vascular; Heart Diseases; In Vitro Techniques; Lisinopril; Male; Myocardial Infarction; Nitrates; Nitrites; Nitroglycerin; omega-N-Methylarginine; Rats; Rats, Wistar; Sodium Nitrite; Sulfhydryl Compounds; Vasodilation; Vasodilator Agents | 2000 |
N-acetylcysteine.
Topics: Acetaminophen; Acetylcysteine; Antidotes; Expectorants; Heart Diseases; Humans; Neoplasms; Respiratory Tract Diseases | 2000 |
PZ-51 (Ebselen) in vivo protection against adriamycin-induced mouse cardiac and hepatic lipid peroxidation and toxicity.
Topics: Acetylcysteine; Animals; Antioxidants; Azoles; Body Weight; Chemical and Drug Induced Liver Injury; Creatine Kinase; Doxorubicin; Drug Interactions; Female; Heart Diseases; Isoindoles; Lipid Peroxidation; Liver Diseases; Mice; Mice, Inbred BALB C; Organoselenium Compounds | 1992 |
Are oxygen radicals responsible for the acute cardiotoxicity of doxorubicin?
Topics: Acetylcysteine; Animals; Doxorubicin; Electrocardiography; Female; Free Radicals; Heart Diseases; In Vitro Techniques; Myocardial Contraction; Oxygen; Oxypurinol; Rats | 1990 |
Amelioration of chronic anthracycline cardiotoxicity by ICRF-187 and other compounds.
Topics: Acetylcysteine; Animals; Dogs; Doxorubicin; Heart Diseases; Piperazines; Razoxane; Swine; Vitamin E | 1987 |
[Experiences on aerosol treatment of bronchopulmonary diseases with tetracycline-1-methylene-lysine combined with acetylcysteine].
Topics: Acetylcysteine; Adolescent; Adult; Aged; Bronchial Diseases; Female; Heart Diseases; Humans; Lung Diseases; Lymecycline; Male; Middle Aged; Tetracycline | 1965 |